# Efficacy and Safety of Oral Antiviral Therapy for Idiopathic Trigeminal Neuralgia

> **NCT07673549** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 165 (estimated)

## Conditions studied

- Idiopathic Trigeminal Neuralgia

## Interventions

- **DRUG:** Intervention：Drug: Carbamazepine
- **DRUG:** Intervention：Drug: Carbamazepine + Acyclovir
- **DRUG:** Intervention：Drug: Carbamazepine + Celecoxib

## Key facts

- **NCT ID:** NCT07673549
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-31
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2026-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673549, "Efficacy and Safety of Oral Antiviral Therapy for Idiopathic Trigeminal Neuralgia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*